Stocks
Personalis, Inc.PSNL
NASDAQHealthcareBiotechnology$6.72+1.97%
A cancer genomics company focused on advanced sequencing and data analytics used in precision oncology. Its platforms support pharmaceutical companies developing immuno-oncology therapies and provide molecular testing for cancer research and clinical applications. Investors track the firm for its ro...
Market Cap: $596.8M52W Range: $2.83 – $11.50
Congressional Interest in Personalis, Inc. (PSNL)
1 member of Congress has disclosed 3 trades in Personalis, Inc. (PSNL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
1
Sells
2
Who in Congress Is Trading PSNL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-05-19 | Brian Mast | sell | $15K – $50K |
| 2020-04-22 | Brian Mast | sell | $1K – $15K |